Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
0.3%
1w
9.1%
1m
10.3%
3m
19.7%
6m
27.1%
1y
6.9%
5y
10.1%
all
22.5%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowJun17Dec18Jun20Dec21Jun23Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

21.7 0.3%
18.5
31.4
Company Overview

Sales
126 Cr
Growth: 3.0%
Profit after Tax
-24 Cr
Growth: 5.7%
Micro Cap
109 Cr
P/S: 0.9x
Industry P/S: 2.6x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 126
Growth 3.0%
EBITDA -0.5%
P/S 0.9x
Dividend 0.0%
P/E -6.9x
Book Value ₹ 17.8
PEG Ratio -2.3x
ROE -25.7%
P/B 1.2x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Mar22Jun23
Promoters
Omkar Pravin Herlekar
64.47 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Mar22Jun23
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Mar22Jun23
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (18)
Followers (3)